Kurt A. Gustafson
2009 - Halozyme Therapeutics
In 2009, Kurt A. Gustafson earned a total compensation of $1.1M as Vice President and Chief Financial Officer at Halozyme Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $4,918 |
|---|---|
| Option Awards | $681,920 |
| Salary | $225,000 |
| Other | $148,573 |
| Total | $1,060,411 |
Gustafson received $681.9K in option awards, accounting for 64% of the total pay in 2009.
Gustafson also received $4.9K in non-equity incentive plan, $225K in salary and $148.6K in other compensation.
Rankings
In 2009, Kurt A. Gustafson's compensation ranked 4,264th out of 9,885 executives tracked by ExecPay. In other words, Gustafson earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,264 out of 9,885 | 57th |
Division Manufacturing | 1,518 out of 3,690 | 59th |
Major group Chemicals And Allied Products | 290 out of 871 | 67th |
Industry group Drugs | 176 out of 643 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 31 out of 138 | 78th |
Source: SEC filing on March 29, 2012.
Gustafson's colleagues
We found eight more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2009
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
News
OmniAb CEO Matthew Foehr's 2023 pay falls 60% to $2.6M
April 26, 2024
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019